What is the official website of Roche Middle East ?

The official website of Roche Middle East is http://www.roche-middleeast.com.

What is Roche Middle East's cybersecurity risk score?

Roche Middle East has an AI-generated cybersecurity risk score of 757 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Roche Middle East experienced?

According to Rankiteo, Roche Middle East currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Roche Middle East been affected by any supply chain cyber incidents ?

According to Rankiteo, Roche Middle East has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Roche Middle East have SOC 2 Type 1 certification ?

According to Rankiteo, Roche Middle East is not certified under SOC 2 Type 1.

Does Roche Middle East have SOC 2 Type 2 certification ?

According to Rankiteo, Roche Middle East does not hold a SOC 2 Type 2 certification.

Does Roche Middle East comply with GDPR ?

According to Rankiteo, Roche Middle East is not listed as GDPR compliant.

Does Roche Middle East have PCI DSS certification ?

According to Rankiteo, Roche Middle East does not currently maintain PCI DSS compliance.

Does Roche Middle East comply with HIPAA ?

According to Rankiteo, Roche Middle East is not compliant with HIPAA regulations.

Does Roche Middle East have ISO 27001 certification ?

According to Rankiteo,Roche Middle East is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Roche Middle East operate in ?

Roche Middle East operates primarily in the Biotechnology Research industry.

How many employees does Roche Middle East have ?

Roche Middle East employs approximately 595 people worldwide.

Does Roche Middle East own any subsidiaries ?

Roche Middle East presently has no subsidiaries across any sectors.

How many LinkedIn followers does Roche Middle East have ?

Roche Middle East's official LinkedIn profile has approximately 84,713 followers.

What is the NAICS classification code for Roche Middle East ?

Roche Middle East is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Roche Middle East have a Crunchbase profile ?

No, Roche Middle East does not have a profile on Crunchbase.

Does Roche Middle East have a LinkedIn profile ?

Yes, Roche Middle East maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/roche-middle-east.

How many cybersecurity incidents has Roche Middle East experienced ?

As of June 18, 2026, Rankiteo reports that Roche Middle East has not experienced any cybersecurity incidents.

How many peer or competitor companies does Roche Middle East have ?

Roche Middle East has an estimated 4,706 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

RME

Boost Score +25 with badge (5 left)

757

/1000

Fair

782

/1000

Fair

Roche Middle East Vendor Cyber Rating & Cyber Score

roche-middleeast.com

Add Your Compliance Badge

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology & neuroscience. Roche is also the world leader in in-vitro diagnostics & tissue-based cancer diagnostics, &a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines & diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by

RME A.I CyberSecurity Scoring

Scoring History

RME

Roche Middle East CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

RME Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for RME

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche Middle East in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Roche Middle East in 2026.

Incident Types RME vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche Middle East in 2026.

Incident History - RME (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Roche Middle East Subsidiaries

RME

Biotechnology Research

Website: http://www.roche-middleeast.com

Company Size: 501-1,000 employees

RocheBiotechnology Research

Roche SwedenTillverkning av läkemedel

GenentechBiotechnology Research

Genentech MedicalBiotechnology Research

Roche MéxicoPharmaceutical Manufacturing

Roche Diabetes CareMedical Equipment Manufacturing

Ventana Medical SystemsBiotechnology Research

Roche Diagnostics BelgiumBiotechnology Research

Roche Diagnostics Asia PacificBiotechnology Research

Roche DanmarkForskning inden for bioteknologi

Roche in Belgium & LuxembourgBiotechnology Research

Roche AustraliaBiotechnology Research

Roche Diagnostics NederlandHospitals and Health Care

Roche Sequencing USABiotechnology Research

中外製薬 / Chugai Pharmaceutical Co., Ltd.Pharmaceutical Manufacturing

Roche Diagnostics AustraliaBiotechnology Research

GenMark DiagnosticsMedical Equipment Manufacturing

Roche VietnamBiotechnology Research

Roche IndonesiaBioteknologi

Roche HungaryBiotechnology Research

Roche Diagnostics DanmarkMedical Equipment Manufacturing

Carmot Therapeutics, Inc.Biotechnology Research

Roche Tunisiaتصنيع المستحضرات الصيدلانية

Roche Malaysia Penyelidikan Bioteknologi

LabLeadersHospitals and Health Care

Roche Hong Kong 羅氏香港Biotechnology Research

Roche IsraelPharmaceutical Manufacturing

Roche Diagnostics SwedenHospitals and Health Care

Roche DeutschlandBiotechnologieforschung

Roche PerúFabricación de productos farmacéuticos

Roche in AustriaArzneimittelherstellung

Roche Diagnostics USABiotechnology Research

Roche BangladeshPharmaceutical Manufacturing

Roche Česká republikaBiotechnologie

Roche Diagnostics PakistanBiotechnology Research

Roche FranceRecherche en biotechnologie

Roche PolskaProdukcja wyrobów farmaceutycznych

Roche Diabetes Care FranceFabrication d’équipements médicaux

Roche Diagnostics FranceFabrication d’équipements médicaux

Roche AfricaBiotechnology Research

Roche CanadaBiotechnology

Roche i NorgeSykehus og helsetjenester

Healthcare TransformersBiotechnology Research

Roche ArgentinaFabricación de productos farmacéuticos

Roche ChileFabricación de productos farmacéuticos

Roche UruguayFabricación de productos farmacéuticos

Roche LATAMPesquisa biotecnológica

Roche CustomBiotech - North AmericaBiotechnology Research

Fondation RocheOrganisations à but non lucratif

Roche EcuadorFabricación de productos farmacéuticos

Roche Costa RicaInvestigación biotecnológica

Loading…

Roche Middle East Similar Companies

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

Amgen

amgen.com

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

The National Institutes of Health

cb nih.gov

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Gilead Sciences

cb gilead.com

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines

Syneos Health

cb syneoshealth.com

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.

Loading…

NEWS

Roche Middle East CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

June 16, 2025 07:00 AM

Markets are shrugging off the Israel-Iran conflict. Some strategists warn of complacency

Global equity markets rose on Monday as fighting in the Middle East escalated.

Read Article

May 30, 2025 07:00 AM

How Veracode is reinventing app security for the AI era

Exclusive Q&A with Brian Roche, CEO, Veracode & Samir Kapuria, MD, Crosspoint Capital.

Read Article

August 21, 2024 07:00 AM

17 Lebanese Execs Just Dominated The Forbes Middle East’s 'Global Meets Local' 2024 List

Forbes Middle East just dropped its "Global Meets Local 2024" list, spotlighting top execs who are making waves by blending global...

Read Article

June 22, 2021 07:00 AM

Unilabs adopts first of its kind diagnostic solutions in the Middle East

Read Article

September 24, 2020 07:00 AM

KPMG appoints 8 partners in Management Consulting division

The unit has seen eight new partners added to its partnership in FY20: Alex Moreno, Barbara-Anne Bensted, Damian Armour, David Kelly, Jennifer Roche, Scott...

Read Article

August 28, 2018 07:00 AM

Roche Diagnostics CEO exits after 10 years

Diggelmann's exit follows a decade of leadership at Roche. The medtech veteran has been with the company since 2008, and took over the diagnostics division in...

Read Article

February 20, 2018 08:00 AM

Signapore's Certis Cisco makes play for Australian market through SNP Security buyout

Singapore's largest aviation security firm Certis Cisco has purchased Australian firm SNP Security for an undisclosed amount.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-48777

SUMMARY

FileBrowser Quantum is a free, self-hosted, web-based file manager. Versions prior to 1.3.2-stable, 1.4.0-beta and 1.4.1-beta are vulnerable to Path Traversal through the publicPatchHandler in backend/http/public.go which joins user-controlled fromPath and toPath body fields with the trusted d.share.Path BEFORE the downstream sanitizer runs. Because filepath.Join collapses .. segments during the join, the sanitizer in resourcePatchHandler never sees the traversal and the move/copy/rename operates on a path outside the shared directory. The same root-cause pattern was patched for the bulk DELETE endpoint as CVE-2026-44542 (GHSA-fwj3-42wh-8673), but the PATCH handler with the identical pattern was not updated. A public share link with AllowModify=true is sufficient to exploit this. Anyone holding such a link can move, copy, or rename arbitrary files within the share owner's source root. This issue has been fixed in versions 1.3.3-stable and 1.4.2-beta.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: )

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47750

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the GLOBAL opcode handler. The issue was caused by missing validation when searching for newline-delimited fields. A crafted .ckpt file without the expected newline could cause the parser to use -1 as a copy length, resulting in immediate heap corruption. The attack requires the victim or application to load a .ckpt file from an untrusted source, such as a downloaded model from a model sharing site. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by following these instructions: do not load .ckpt checkpoint files from untrusted sources, and prefer trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-47747

SUMMARY

stable-diffusion.cpp is a pure C/C++ library for running diffusion model (Stable Diffusion, Flux, Wan, Qwen Image, Z-Image, and more) inference. In versions prior to master-584-0a7ae07, the pickle .ckpt parser in src/model.cpp contained a heap buffer overflow vulnerability in the BINUNICODE opcode handler. The issue was caused by sign confusion on the opcode length field. A crafted .ckpt file could trigger memcpy with a very large length derived from a negative signed value, causing immediate heap corruption. The issue has been resolved in version master-584-0a7ae07. If developers are unable to immediately update their applications they can work around this issue by only loading .ckpt checkpoint files from trusted sources and preferring trusted model sources and safer formats such as .safetensors where possible.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

CVE-2026-46448

SUMMARY

In OpenStack Nova before 33.0.2, the server create API does not strip certain hint data. The resulting instance has no Placement allocation.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-22313

SUMMARY

The device has a webserver that exposes a REST API authenticated with a token on the management network. By exploiting an OS command injection vulnerability an authenticated attacker can send arbitrary commands to the device that are executed with administrative permissions by the underlying operating system.

Published

Date2026-06-16

Updated

Date2026-06-16

RISK INFORMATION (Score: 9.1)

cvss3

Base Score: 9.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H

Impact Score

Exploitability

2.3

REFERENCES

https://www.cvcn.gov.it/cvcn/cve/CVE-2026-22313

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…